Heterozygous loss-of-function mutations in NR0B2 in OMIM (*604630) are associated with mild early-onset obesity, whereas truncating mutations in GCKR may be linked to increased levels of blood triglycerides [29]. Here, GCKR is linked to obesity due to melanocortin 4 receptor deficiency.